Global Contraceptive Sponges Market Size, Share, Trends, COVID-19 Impact & Growth Forecast Report – Segmented By Type (Ultrathin and Ordinary), Distribution Channel (Pharmacies, Online Stores and Others) and Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa) - Industry Analysis (2024 to 2029)

Updated On: January, 2024
ID: 9231
Pages: 175

Global Contraceptive Sponges Market Size (2024 to 2029)

The size of the global contraceptive sponges market is estimated to grow from USD 189.85 Mn in 2024 to USD 238.4 Mn by 2029, growing at a CAGR of 4.66% from 2024 to 2029.

The contraceptive sponge is a type of contraception that prevents sperm from entering the uterus. They are usually soft, disk-shaped, and made of polyurethane foam. Contraceptive sponges contain spermicides that block or kill sperm and this device is interested in the vagina before sexual intercourse. These are generally 2 inches in diameter and have a ring for easy removal. The method of medication used for contraception interferes with the ordinary course of sperm-egg fertilization to prevent pregnancy.

Global Contraceptive Sponges Market Drivers:

As the importance of family planning increases, the global market for contraceptive sponges is predicted to grow. Compared to birth control pills, the safety associated with birth control sponges is also one of the undoubted reasons for the growth of the market for these sponges. The contraceptive sponge can be used for a long time without removing it, regardless of the number of sexual intercourses, due to which sales of contraceptive sponges are also supposed to increase.

The increase in family planning programs and the adoption of voluntary family planning measures are expected to stimulate the market for contraceptive sponges. Contraceptives can cause health-related complications, but they are safe to use. They also showed essential results in preventing pregnancy. Another factor that is predicted to accelerate the growth of the market for contraceptive sponges is that it is easy to use and does not interfere with sex. The use of social media marketing to inform people about contraceptive sponges is also driving growth. 

A spermicide impregnated with a contraceptive sponge kills the sperm and prevents it from reaching the uterus. Especially in women who have not been previously administered, the high effect of sponges is likely to lead to the growth of the global contraceptive sponges market. These sponges are readily available, are over the counter (OTC) drugs, and are available in pharmacy stores. E-commerce or online pharmacies are expected to make this distribution channel more accessible and more comfortable to access, resulting in the fastest-growing end-user segment.

Global Contraceptive Sponges Market Restraints:

However, these contraceptive sponges cannot prevent sexually transmitted diseases, which can be a market limitation. Contraceptive sponges are not as effective as condoms to avoid pregnancy, restricting the rapid extension of the global market. The main challenge in the market is that contraceptive sponges cannot prevent sexually transmitted diseases such as HIV and AIDS, and many competitive products such as condoms and pills are more effective in preventing pregnancy.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2023 to 2029

Base Year

2023

Forecast Period

2024 to 2029

CAGR

4.66%

Segments Covered

Based on Type, Distribution channel and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, The Middle East and Africa

 

 

Market Leaders Profiled

Teva Pharmaceutical Industries Limited, Pirri Pharma, Tree of Life Pharma, Merck & Co., Inc., Women's Health Company, Allergan plc, Pfizer, Inc., Bayer AG, Innotech International, Cooper Companies, Inc., Mayer Laboratories, Ansell LTD., Sager Pharma Kft, and Innothera

 

This research report on the global contraceptive sponges market has been segmented and sub-segmented based on type, distribution channel and region.

Global Contraceptive Sponges Market - By Type:

  • Ordinary
  • Ultrathin

Global Contraceptive Sponges Market - By Distribution Channel:

  • Pharmacies
  • Online stores
  • Others

The pharmacies, comprising both retail and hospital, accounted for the most substantial portion of the worldwide market in the review period. However, in the coming years, online stores are predicted to witness the highest demand because of the convenience and doorstep delivery they offer. The increasing penetration of smartphones and the internet will act as a catalyst for the expansion of the online segment in this industry.

Global Contraceptive Sponges Market – By Region:

  • North America
    • The United States
    • Canada
    • Rest of North America
  • Europe
    • The United Kingdom
    • Spain
    • Germany
    • Italy
    • France
    • Rest of Europe
  • The Asia Pacific
    • India
    • Japan
    • China
    • Australia
    • Singapore
    • Malaysia
    • South Korea
    • New Zealand
    • Southeast Asia
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • UAE
    • Lebanon
    • Jordan
    • Cyprus

KEY MARKET PLAYERS:

Companies playing a major role in the global contraceptive sponges market include Teva Pharmaceutical Industries Limited, Pirri Pharma, Tree of Life Pharma, Merck & Co., Inc., Women's Health Company, Allergan PLC, Pfizer, Inc., Bayer AG, Innotech International, Cooper Companies, Inc., Mayer Laboratories, Ansell LTD., Sager Pharma KFT and Innothera.

RECENT HAPPENINGS IN THE MARKET:

  • Mayor Laboratories, Inc., a US-based company that manufactures and sells health and reproductive products, has hired Blossom Organics, Inc. to distribute the company's intimately and naturally purely managed products exclusively to all retail, wholesale, and government channels. Signed by the United States, Europe, and Canada.

When I submit this form, I am consenting to Market Data Forecast Privacy Policy.

Frequently Asked Questions

What is the current size of the global contraceptive sponges market?

The global contraceptive sponges market is anticipated to be worth USD 189.85 Million in 2024.

Which regions contribute significantly to the global contraceptive sponges market share?

The global contraceptive sponges market sees notable contributions from North America, Europe, and Asia-Pacific, with varying adoption rates and regulatory landscapes in each region.

How does the regulatory environment in North America impact the contraceptive sponges market?

In North America, regulatory approvals from health authorities influence the availability and marketing of contraceptive sponges. Compliance with regulatory standards is crucial for market entry and growth.

Who are the major companies in the global contraceptive sponges market?

Teva Pharmaceutical Industries Limited, Pirri Pharma, Tree of Life Pharma, Merck & Co., Inc., Women's Health Company, Allergan PLC, Pfizer, Inc., Bayer AG, Innotech International, Cooper Companies, Inc., Mayer Laboratories, Ansell LTD., Sager Pharma KFT and Innothera are some of the key players in the global market.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample